Literature DB >> 19501723

Normal pressure hydrocephalus.

Glen R Finney1.   

Abstract

Normal Pressure Hydrocephalus first became recognized as a treatable, reversible disorder in the 1960s. The classic triad of magnetic apraxia, urinary incontinence, and dementia remain relevant into the 21(st) century as being the basis for symptomatic diagnosis and predicting potential benefit from ventriculoperitoneal shunting, though they have been greatly augmented by the addition of modern neuroimaging, particularly MRI. Modern criteria recognize a wider range of diagnostic criteria, and new positive and negative prognostic indicators for treatment benefit have been discovered, though the mainstay remains initial drainage of a large volume of cerebrospinal fluid and monitoring for clinical improvement. Even with our advances in understanding both primary and secondary normal pressure hydrocephalus, diagnosis, management, and counseling remain challenging in this disorder.

Entities:  

Mesh:

Year:  2009        PMID: 19501723     DOI: 10.1016/S0074-7742(09)00414-0

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  3 in total

1.  Longitudinal Metabolite Profiling of Cerebrospinal Fluid in Normal Pressure Hydrocephalus Links Brain Metabolism with Exercise-Induced VEGF Production and Clinical Outcome.

Authors:  He Huang; Jun Yang; Mark Luciano; Leah P Shriver
Journal:  Neurochem Res       Date:  2016-04-15       Impact factor: 3.996

2.  Differentiating shunt-responsive normal pressure hydrocephalus from Alzheimer disease and normal aging: pilot study using automated MRI brain tissue segmentation.

Authors:  Yafell Serulle; Henry Rusinek; Ivan I Kirov; Hannah Milch; Els Fieremans; Alexander B Baxter; John McMenamy; Rajan Jain; Jeffrey Wisoff; James Golomb; Oded Gonen; Ajax E George
Journal:  J Neurol       Date:  2014-08-01       Impact factor: 4.849

3.  Normal pressure hydrocephalus as an unusual presentation of supratentorial extraventricular space-occupying processes: report on two cases.

Authors:  E Naydenov; V Bussarsky; K Minkin; A Bussarsky; S Nachev; L Traykov
Journal:  Case Rep Oncol       Date:  2012-03-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.